| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/25/2002 | US6410245 Complexing; fusion proteins; quantitative analysis |
| 06/25/2002 | US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | WO2002048157A2 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors |
| 06/20/2002 | WO2002047711A2 Modulators of activity of g-protein-coupled receptor kinases |
| 06/20/2002 | WO2002047710A2 Use of inhibitors of lyn-associated signal transduction (last) in the treatment of prostate cancer |
| 06/20/2002 | WO2001090194A3 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 06/20/2002 | WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 06/20/2002 | WO2001090139A3 A ligand for enhancing oral and cns delivery of biological agents |
| 06/20/2002 | WO2001077113A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 06/20/2002 | WO2001009165A8 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 06/20/2002 | US20020076782 Controlling nitric oxide generation in mammals; obtain mammal, administer modulator, monitor nitric oxide generation |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | US20020076378 Radically asymmetric dendrimeric polymer (polylactam) backbone linked to at least one reporter moiety; contrast agents which contain large amounts of metal per molecule |
| 06/20/2002 | DE10061525A1 New tetradecapeptides, containing alpha-aminoisobutyric acid residues and a terminal leucinol residue, useful for forming central nervous system-penetrating lipophilic conjugates of drugs, e.g. antibiotics |
| 06/20/2002 | DE10061161A1 Neue humane Androgenrezeptor-Varianten New human androgen receptor variants |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430458A1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/19/2002 | EP1214448A1 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 06/19/2002 | EP1214350A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 06/19/2002 | EP1214336A1 Synthesis of template-fixed beta-hairpin loop mimetics |
| 06/19/2002 | EP1214335A1 Gamma-carboxyglutamate containing conopeptides |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | CN1354788A Cyclic peptides |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407206 Peptides, methods for assaying human pepsinogen I or human pepsin I and assay kits |
| 06/18/2002 | US6407205 Increasing fertility of vertibrates by administering lamprey luteinizing hormone releasing factor ii |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6407059 Conformationally constrained backbone cyclized peptide analogs |
| 06/18/2002 | CA2034611C Synthetic peptide compositions with immunoreactivities to antibodies to htlv |
| 06/18/2002 | CA2025019C Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1 |
| 06/13/2002 | WO2002045524A2 Prolyl endoprotease from aspergillus niger |
| 06/13/2002 | WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/13/2002 | WO2002045479A1 Portable, motor-powered shears |
| 06/13/2002 | WO2002017948A3 Control of crop pests and animal parasites through direct neuronal uptake |
| 06/13/2002 | WO2002012278A3 Pseudo-metalloproteins, corresponding preparation and use as biosensors |
| 06/13/2002 | WO2001094547A3 Molecular delivery vehicle for delivery of selected compounds to targets |
| 06/13/2002 | WO2001092294A3 Therapeutic anti-melanoma compounds |
| 06/13/2002 | WO2001074844A3 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 06/13/2002 | WO2001072277A3 Immunotherapeutic methods and compositions |
| 06/13/2002 | US20020072586 Chiral peptide nucleic acids |
| 06/13/2002 | US20020072487 Method for searching physiologically active substances, process for producing these substances and drugs found by the searching method |
| 06/13/2002 | US20020072074 Solid support for use as diagnostic tool in the analysis and separation of biopolymers |
| 06/13/2002 | CA2430893A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/12/2002 | EP1213300A1 Novel human androgen receptor variants |
| 06/12/2002 | EP1213298A1 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/12/2002 | EP1213297A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212353A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf) |
| 06/12/2002 | EP1212352A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 06/12/2002 | EP1212351A1 Method for producing cyclic peptidomimetics |
| 06/12/2002 | EP1212348A2 Purification and analysis of cyclic peptide libraries, and compositions thereof |
| 06/12/2002 | EP0749325B1 Bispecific molecules having clinical utilities |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0639269B1 Ionic reservoir at electrode surface |
| 06/11/2002 | US6403957 Nucleic acid reading and analysis system |
| 06/11/2002 | US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology |
| 06/11/2002 | US6403555 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/11/2002 | US6403320 Support bound probes and methods of analysis using the same |
| 06/11/2002 | US6403090 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/06/2002 | WO2002044329A2 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/06/2002 | WO2002043773A2 Tissue specific prodrugs |
| 06/06/2002 | WO2002043746A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/06/2002 | WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 06/06/2002 | WO2002018437A3 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 06/06/2002 | WO2001079242A3 Process for preparing lipid ii and derivatives thereof |
| 06/06/2002 | WO2001074768A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/06/2002 | WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 06/06/2002 | US20020068702 Containing eleven amino acid residues |
| 06/06/2002 | US20020068699 Clostridial toxin derivatives and methods for treating pain |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068695 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 06/06/2002 | US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 06/06/2002 | US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator) |
| 06/06/2002 | CA2449412A1 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/06/2002 | CA2428552A1 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 06/05/2002 | EP1210606A1 Cartilage resorption assays |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210373A2 Congener independent detection of microcystin and nodularin congeners |
| 06/05/2002 | EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1141375A4 Metallopeptide combinatorial libraries and applications |
| 06/05/2002 | EP1071442A4 Methods and compositions for peptide synthesis |
| 06/05/2002 | EP0951474B1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0951473B1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same |
| 06/05/2002 | EP0948527B1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0904096A4 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
| 06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
| 06/05/2002 | CN1352649A Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus |
| 06/04/2002 | US6399771 Cyclic imines as pesticides |
| 06/04/2002 | US6399575 Methods and compositions for targeting compounds to the central nervous system |
| 06/04/2002 | US6399567 Cyclic hexapeptides having antibiotic activity |
| 06/04/2002 | US6399296 Detecting specific protein in sample by contacting with second protein having reduced structural flexibility due to recombinantly introduced disulfide bonding, allowing proteins to complex, then detecting complex |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |